Vivakor Extends Its Business Development Agreement With Baker Consulting

CORALVILLE, Iowa, June 7, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK - News) has extended its Business Development agreement with Baker Consulting out of Walnut Creek, California and its affiliate group, Kyouko Group, Inc. out of South Florida for an additional six months. Baker Consulting has made great strides in assisting the company with distribution agreements and research collaboration. Vivakor's Chairman Matt Nicosia stated recently, "Baker Consulting, with its vast experience in medical device commercialization and corporate finance, has been very instrumental in our Company's commercialization efforts and we are very pleased in the progress that has been made thus far and we look forward to creating great value for Vivakor shareholders through this relationship."



About Vivakor, Inc.



Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handing and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.



FORWARD-LOOKING STATEMENTS



This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.